VCEL Q4 2023 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$65M+23.3% YoY

Gross Profit

$49M74.6% margin

Operating Income

$13M19.6% margin

Net Income

$13M20.0% margin

EPS (Diluted)

$0.26

QoQ Revenue Growth

+42.6%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$2M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$354M

Total Liabilities

$128M

Stockholders' Equity

$226M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65M	$53M	+23.3%
Gross Profit	$49M	$38M	+26.8%
Operating Income	$13M	$6M	+109.2%
Net Income	$13M	$6M	+119.4%

Revenue Segments

MACI Implants And Kits

$94M100%